
|Videos|July 27, 2015
The Lessons of High Cost Specialty Drug Product Launches
Author(s)Davy James, Managing Editor
David D'Altorio, PharmD, senior vice president of health services at MedImpact Healthcare Systems, Inc, discusses takeaways from the impact of high cost drug launches on specialty pharmacy.
Advertisement
David D'Altorio, PharmD, senior vice president of health services at MedImpact Healthcare Systems, Inc, discusses takeaways from the impact of high cost drug launches on specialty pharmacy.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Removes Black Boxed Warning From Hormone Therapies for Menopause
2
The Average Health Insurance Premium Now Costs $27k Per Year for a Family
3
Major Review Finds No Link Between Maternal Tylenol and Autism Spectrum Disorder, ADHD
4
Opinion: Pharmacists Are Critical to Ensure Safe, Ethical Integration of AI in Health Care
5
















































































































































































































